Tumor-associated Macrophages Promote Tumor Metastasis Via the TGF-β/SOX9 Axis in Non-small Cell Lung Cancer
Overview
Authors
Affiliations
Tumor-associated macrophages (TAMs), most of which display the immunosuppressive M2 phenotype, affect the tumor microenvironment and promote progression and metastasis in lung carcinoma. In this study, we analyzed clinical non-small cell lung cancer (NSCLC) samples and found that high densities of TAMs were associated with a poor prognosis in NSCLC patients. Moreover, the number of TAMs present correlated positively with expression of sex determining region Y (SRY)-related high mobility group box 9 (SOX9) in NSCLC tissues. TAMs secreted TGF-β, which increased SOX9 expression and promoted epithelial-to-mesenchymal transition (EMT) in lung cancer cells, thereby promoting tumor proliferation, migration, and invasion. SOX9 knockdown inhibited EMT, indicating that TGF-β-mediated EMT is SOX9-dependent. TGF-β induced SOX9 expression by upregulating the C-jun/SMAD3 pathway. These results indicate that TGF-β secreted by TAMs promotes SOX9 expression via the C-jun/SMAD3 pathway, thereby promoting tumor metastasis. The TGF-β/SOX9 axis may therefore be an effective target for the treatment of lung cancer.
The role of tumor-associated macrophages in lung cancer.
Zhu R, Huang J, Qian F Front Immunol. 2025; 16:1556209.
PMID: 40079009 PMC: 11897577. DOI: 10.3389/fimmu.2025.1556209.
Non-small cell lung cancer map and analysis: exploring interconnected oncogenic signal integrators.
Gottumukkala S, Palanisamy A Mamm Genome. 2025; .
PMID: 39939487 DOI: 10.1007/s00335-025-10110-6.
Tumor-Associated Macrophages: Key Players in the Non-Small Cell Lung Cancer Tumor Microenvironment.
Lv T, Fan R, Wu J, Gong H, Gao X, Liu X Cancer Med. 2025; 14(3):e70670.
PMID: 39927632 PMC: 11808749. DOI: 10.1002/cam4.70670.
Zhao Y, Zhao L, Li M, Meng Z, Wang S, Li J World J Surg Oncol. 2024; 22(1):254.
PMID: 39300515 PMC: 11414033. DOI: 10.1186/s12957-024-03536-w.
Whately K, Sengottuvel N, Edatt L, Srivastava S, Woods A, Tsai Y JCI Insight. 2024; 9(9).
PMID: 38716730 PMC: 11141919. DOI: 10.1172/jci.insight.168792.